dalteparin has been researched along with Brachial Paresis in 2 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellido, M | 1 |
| van der Velden, VH | 1 |
| Leebeek, FW | 1 |
| te Boekhorst, PA | 1 |
| Verma, R | 1 |
| Patil, TB | 1 |
| Kumar, N | 1 |
2 other studies available for dalteparin and Brachial Paresis
| Article | Year |
|---|---|
Thrombotic complications without evidence of hemolysis in paroxysmal nocturnal hemoglobinuria: Is eculizumab indicated?
Topics: Adult; Anemia, Aplastic; Anticoagulants; Brain Ischemia; Cerebral Hemorrhage; Fatal Outcome; Hemoglo | 2012 |
Early recanalisation of cerebral venous sinus thrombosis in an unusual case associated with severe protein S deficiency.
Topics: Adult; Anticoagulants; Enoxaparin; Headache; Heparin, Low-Molecular-Weight; Humans; Male; Paresis; P | 2012 |